Ledger.Open graph →
SEC Form D · Amendment · filed December 23, 2022

ZWI Therapeutics, Inc

Offering
$10.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
WATERTOWN, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Shaoyi Jiang · Shoreline, WADirectorAndrew Keefe · CAMBRIDGE, MAExec · DirectorXin Huang · Baltimore, MDDirectorRobert Langer · Bedford, MADirectorCheng Xing · CAMBRIDGE, MADirectorShaoyi Jiang · Shoreline, WADirectorAndrew Keefe · CAMBRIDGE, MAExec · DirectorXin Huang · Baltimore, MDDirectorRobert Langer · PITTSBURGH, PADirectorCheng Xing · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗